UNITY Biotechnology

UNITY Biotechnology is developing a new class of therapies aimed at slowing, halting, or reversing age-related diseases. UNITY’s current focus is on creating drugs that can selectively eliminate or modulate senescent cells, offering transformative benefits for age-related ophthalmic and neurological conditions.